000 | 01225 a2200313 4500 | ||
---|---|---|---|
005 | 20250514183443.0 | ||
264 | 0 | _c20041102 | |
008 | 200411s 0 0 eng d | ||
022 | _a0305-1870 | ||
024 | 7 |
_a10.1111/j.1440-1681.2004.03982.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnjaneyulu, Muragundla | |
245 | 0 | 0 |
_aQuercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. _h[electronic resource] |
260 |
_bClinical and experimental pharmacology & physiology _cApr 2004 |
||
300 |
_a244-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
650 | 0 | 4 |
_aDiabetic Nephropathies _xdrug therapy |
650 | 0 | 4 |
_aFlavonoids _xtherapeutic use |
650 | 0 | 4 |
_aKidney Failure, Chronic _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aQuercetin _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
700 | 1 | _aChopra, Kanwaljit | |
773 | 0 |
_tClinical and experimental pharmacology & physiology _gvol. 31 _gno. 4 _gp. 244-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1681.2004.03982.x _zAvailable from publisher's website |
999 |
_c14770241 _d14770241 |